PEAK6 Investments’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$812K Buy
+8,268
New +$1.07M ﹤0.01% 2040
2023
Q4
Sell
-200
Closed -$88.8K 4153
2023
Q3
$88.8K Sell
200
-80
-29% -$36.1K ﹤0.01% 3442
2023
Q2
$121K Sell
280
-1,112
-80% -$625K ﹤0.01% 3150
2023
Q1
$827K Buy
+1,392
New +$780K ﹤0.01% 1986
2022
Q3
Sell
-280
Closed -$121K 4867
2022
Q2
$121K Buy
+280
New +$142K ﹤0.01% 5131
2021
Q4
Sell
-740
Closed -$485K 5033
2021
Q3
$485K Buy
+740
New +$632K ﹤0.01% 3289

Other funds holding AGL

PEAK6 Investments's AGL Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Agilon Health (AGL) in Q3 2024: 1,170 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #2953 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in AGL as recently as Q3 2023.

PEAK6 Investments first reported a position in AGL in Q4 2021 and has held it in 6 quarters since. The position peaked at $340K in Q3 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • PEAK6 Investments held 1,170 shares of Agilon Health worth $115K as of Q3 2024.
  • Agilon Health was a new PEAK6 Investments position in Q3 2024.
  • Agilon Health made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2953 holding.
  • PEAK6 Investments first reported a position in Agilon Health in Q4 2021 and has held it in 6 quarters since.
  • PEAK6 Investments's Agilon Health position peaked at $340K in Q3 2023.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.